Valencia Technologies Corporation

Valencia Technologies is a neuromodulation medical device company specializing in minimally invasive treatment of bladder dysfunction and urinary incontinence. The company's flagship product, the eCoin® system, is a leadless, implantable tibial nerve stimulator FDA-approved in 2022 for Urge Urinary Incontinence (UUI). The eCoin device is coin-sized, implanted subcutaneously near the ankle under local anesthesia, and eliminates the need for lead wires, external remotes, recharging, or general anesthesia. The company operates a manufacturing facility in Valencia, California with cleanroom assembly and testing capabilities, and holds 52 patents related to its neuromodulation technology. Valencia Technologies is now part of Boston Scientific and aims to enable most eCoin procedures to be performed in outpatient clinics.